{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-028332","form_type":"8-K","ticker":"APUS","cik":"0001894525","company_name":"Apimeds Pharmaceuticals US, Inc.","filed_at":"2026-03-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.699316+00:00","generated_at":"2026-05-15T11:56:59.282897+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Apimeds Pharmaceuticals to effect 1-for-10 reverse stock split on March 26, 2026","bullets":["Stockholders approved 1-for-10 reverse stock split via written consent in December 2025.","Reverse split effective 12:01 a.m. ET March 26, 2026; trading begins on split-adjusted basis same day.","Every 10 pre-split shares convert to 1 share; new CUSIP 03771D201.","Company expects to file charter amendment with Delaware Secretary of State around March 25."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-028332","json":"https://secwatch.observer/filing/0001213900-26-028332.json","markdown":"https://secwatch.observer/filing/0001213900-26-028332.md","text":"https://secwatch.observer/filing/0001213900-26-028332.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026028332/0001213900-26-028332-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026028332/ea0281820-8k_apimeds.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T11:56:59.282897+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}